There is no doubt that once PRR lists on the NASDAQ we will see a massive spike in the share price.
An example of another biotech company is UNS. In the month leading to listing it went from $1.055 to $1.40. Upon listing it shot to $1.78. It has now retraced to $0.82 due to mismanagement etc.
PRR is a diffferent kettle of fish though with more potential. If UNS was able to go up 70%, PRR will be able to double it's current price upon listing.
Please DYOR as my research is based on historical data and events.
trading on nasdaq, page-2
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
28.0¢ |
Change
-0.005(1.75%) |
Mkt cap ! $406.7M | |||
| Open | High | Low | Value | Volume |
| 29.0¢ | 29.0¢ | 27.5¢ | $1.341M | 4.777M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 167966 | 28.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 28.5¢ | 138542 | 5 |
View Market Depth
| Last trade - 16.10pm 04/07/2024 (20 minute delay) ? |
| IMM (ASX) Chart |